Back to Search Start Over

299 (PB-115) Poster - Improved Chemosensitivity Prediction for HR+HER2- Breast Cancer Patients with MammaPrint High2 risk group in the FLEX Trial.

Authors :
O'Shaughnessy, J.
Sonnenblick, A.
Strulov Shachar, S.
Kümmel, S.
Fischer, L.A.
Rezek, D.
Pronin, D.
Menicucci, A.
Audeh, W.
Source :
European Journal of Cancer. Mar2024:Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Details

Language :
English
ISSN :
09598049
Volume :
200
Database :
Academic Search Index
Journal :
European Journal of Cancer
Publication Type :
Academic Journal
Accession number :
176071006
Full Text :
https://doi.org/10.1016/j.ejca.2024.113866